Roche Holding AG Roche Holding AG

Roche Holding AG

RO

Classifica tra le azioni #44
Roche Holding AG is a global healthcare enterprise with dual focuses:... Roche Holding AG is a global healthcare enterprise with dual focuses: pharmaceuticals and diagnostics. The company maintains a significant presence in numerous countries, including its home base in Switzerland, alongside Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and various other international markets. Its pharmaceutical segment develops and supplies treatments for a wide spectrum of medical conditions, encompassing oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments, as well as specific therapies for anemia, dermatology, hemophilia, inflammatory and autoimmune conditions, and transplant patients. On the diagnostic front, Roche provides in vitro tests designed to identify various diseases like cancer, diabetes, COVID-19, hepatitis, and human papillomavirus, in addition to supplying crucial diagnostic instruments and reagents. The company was founded in Basel, Switzerland, in 1896.
Prezzo delle azioni
$500.46
Ultima sincronizzazione: 2026-10-19
Capitalizzazione di mercato
$340.50B
Variazione (1 giorno)
0.05%
Variazione (1 anno)
34.35%
Paese
CH
Scambia Roche Holding AG (RO)

Categoria

Healthcare
Storico del rendimento da dividendi per Roche Holding AG (RO)
Il rendimento da dividendi (TTM) di Roche Holding AG (simbolo azionario: RO) al 2026 è: 0
Rendimento medio negli ultimi 5 anni: 0.00%
Storico del rendimento da dividendi per Roche Holding AG (RO) da 2026 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
Anno Rendimento da dividendi Cambia
Non abbastanza dati per le date fornite.
Rendimenti da dividendi (TTM) di aziende simili o concorrenti
Azienda Rendimento da dividendi Il paese
0.55%
US
2.08%
US
2.44%
US
2.31%
US
2.80%
CH